These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

93 related articles for article (PubMed ID: 4588425)

  • 1. The effect of trypsin on cell suspensions and culture supernatants of strains of Clostridium botulinum types B and E.
    Tjaberg TB
    Acta Pathol Microbiol Scand B Microbiol Immunol; 1973 Apr; 81(2):187-90. PubMed ID: 4588425
    [No Abstract]   [Full Text] [Related]  

  • 2. Proteases of Clostridium botulinum. VI. The role of trypsin, Clostridium botulinum proteases and protease inhibitors in the formation and activation of toxin in growing cultures of Clostridium botulinum.
    Tjaberg TB
    Acta Vet Scand; 1974; 15(4):487-506. PubMed ID: 4616624
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Activation of a toxic component of Clostridium botulinum types C and D by trypsin.
    Eklund MW; Poysky FT
    Appl Microbiol; 1972 Jul; 24(1):108-13. PubMed ID: 4560464
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Role of a protease in natural activation of Clostridium botulinum neurotoxin.
    Das Gupta BR; Sugiyama H
    Infect Immun; 1972 Oct; 6(4):587-90. PubMed ID: 4564288
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Responses of Clostridium botulinum type B and E progenitor toxins to some clostridial sulfhydryl-dependent proteases.
    Oishi I; Okada T; Sakaguchi G
    Jpn J Med Sci Biol; 1975 Jun; 28(3):157-64. PubMed ID: 1104932
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Activation of botulinum toxins in the absence of nicking.
    Ohishi I; Sakaguchi G
    Infect Immun; 1977 Aug; 17(2):402-7. PubMed ID: 19360
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Activation of Clostridium botulinum type E toxin by trypsin.
    DUFF JT; WRIGHT GG; YARINSKY A
    J Bacteriol; 1956 Oct; 72(4):455-60. PubMed ID: 13366946
    [No Abstract]   [Full Text] [Related]  

  • 8. Enzyme-linked immunosorbent assay for detection of Clostridium botulinum type E toxin.
    Notermans S; Dufrenne J; Kozaki S
    Appl Environ Microbiol; 1979 Jun; 37(6):1173-5. PubMed ID: 384908
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Tryptic activation of Clostridium botulinum type C beta toxin.
    Jansen BC; Knoetze PC
    Onderstepoort J Vet Res; 1971 Dec; 38(4):237-8. PubMed ID: 5164858
    [No Abstract]   [Full Text] [Related]  

  • 10. Different response of the knockout mice lacking b-series gangliosides against botulinum and tetanus toxins.
    Kitamura M; Igimi S; Furukawa K; Furukawa K
    Biochim Biophys Acta; 2005 Jun; 1741(1-2):1-3. PubMed ID: 15919183
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Response of type B and E Botulinum toxins to purified sulfhydryl-dependent protease produced by Clostridium botulinum type F.
    Ohishi I; Sakaguchi G
    Jpn J Med Sci Biol; 1977 Aug; 30(4):179-90. PubMed ID: 20527
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Oral toxicities of Clostridium botulinum type E toxins of different forms.
    Sakaguchi G; Sakaguchi S
    Jpn J Med Sci Biol; 1974 Aug; 27(4):241-4. PubMed ID: 4606876
    [No Abstract]   [Full Text] [Related]  

  • 13. [Production of the trypsin-activable toxin by Clostridium botulinum type C and D strains (author's transl)].
    Nakane A
    Nihon Saikingaku Zasshi; 1977 Nov; 32(6):805-11. PubMed ID: 342740
    [No Abstract]   [Full Text] [Related]  

  • 14. [Effect of enrichment of Wrzosek's culture medium with some amino acids on the growth of Cl. botulinum and the biosynthesis of its toxins].
    Matras J
    Med Dosw Mikrobiol; 1974; 26(4):291-301. PubMed ID: 4613973
    [No Abstract]   [Full Text] [Related]  

  • 15. Use of monoclonal antibodies in enzyme linked immunosorbent assay (ELISA) for detection of botulinum type B toxins.
    Notermans S; Kozaki S; Kamata Y; Sakaguchi G
    Jpn J Med Sci Biol; 1984 Jun; 37(3):137-40. PubMed ID: 6389944
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Production of trypsin-activable toxic components by Clostridium botulinum types C and D [proceedings].
    Nakane A; Oguma K; Shiozaki M; Iida H
    Jpn J Med Sci Biol; 1978 Apr; 31(2):166-9. PubMed ID: 355684
    [No Abstract]   [Full Text] [Related]  

  • 17. Molecular structures and biological activities of Clostridium botulinum toxins.
    Sakaguchi G; Oishi I; Kozaki S; Sakaguchi S; Kitamura M
    Jpn J Med Sci Biol; 1974 Apr; 27(2):95-9. PubMed ID: 4601038
    [No Abstract]   [Full Text] [Related]  

  • 18. Effect of frozen storage time on heat inactivation of Clostridium botulinum type E toxin.
    Yao MG; Denny CB; Bohrer CW
    Appl Microbiol; 1973 Mar; 25(3):503-5. PubMed ID: 4572899
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Clostridium botulinum subtype Ba.
    Giménez DF
    Zentralbl Bakteriol Mikrobiol Hyg A; 1984 May; 257(1):68-72. PubMed ID: 6380157
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Nicking of single chain Clostridium botulinum type A neurotoxin by an endogenous protease.
    Dekleva ML; DasGupta BR
    Biochem Biophys Res Commun; 1989 Jul; 162(2):767-72. PubMed ID: 2667520
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.